The University of Chicago Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Rex C. Haydon and Tong-Chuan He.
Rex C. Haydon
Connection Strength
12.173
Tong-Chuan He
  1. Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis. Clin Orthop Relat Res. 2007 Jan; 454:237-46.
    View in: PubMed
    Score: 0.313
  2. Tyrosine kinase inhibitor STI-571: the new wonder drug of cancer therapy. Cancer Biol Ther. 2004 Apr; 3(4):393-4.
    View in: PubMed
    Score: 0.259
  3. Bone Morphogenic Protein 9 (BMP9)/Growth Differentiation Factor 2 (GDF2) modulates mouse adult hippocampal neurogenesis by regulating the survival of early neural progenitors. Genes Dis. 2023 Jul; 10(4):1175-1179.
    View in: PubMed
    Score: 0.241
  4. Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma. Int J Cancer. 2002 Dec 01; 102(4):338-42.
    View in: PubMed
    Score: 0.236
  5. Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. Clin Cancer Res. 2002 May; 8(5):1288-94.
    View in: PubMed
    Score: 0.226
  6. Melanoma: Molecular genetics, metastasis, targeted therapies, immunotherapies, and therapeutic resistance. Genes Dis. 2022 Nov; 9(6):1608-1623.
    View in: PubMed
    Score: 0.226
  7. OUHP: an optimized universal hairpin primer system for cost-effective and high-throughput RT-qPCR-based quantification of microRNA (miRNA) expression. Nucleic Acids Res. 2022 02 28; 50(4):e22.
    View in: PubMed
    Score: 0.224
  8. Correction: Adenovirus-Mediated Efficient Gene Transfer into Cultured Three-Dimensional Organoids. PLoS One. 2021; 16(10):e0259544.
    View in: PubMed
    Score: 0.219
  9. The inhibition of BRAF activity sensitizes chemoresistant human ovarian cancer cells to paclitaxel-induced cytotoxicity and tumor growth inhibition. Am J Transl Res. 2020; 12(12):8084-8098.
    View in: PubMed
    Score: 0.206
  10. A reverse transcriptase-mediated ribosomal RNA depletion (RTR2D) strategy for the cost-effective construction of RNA sequencing libraries. J Adv Res. 2020 Jul; 24:239-250.
    View in: PubMed
    Score: 0.193
  11. lncRNA Rmst acts as an important mediator of BMP9-induced osteogenic differentiation of mesenchymal stem cells (MSCs) by antagonizing Notch-targeting microRNAs. Aging (Albany NY). 2019 12 11; 11(24):12476-12496.
    View in: PubMed
    Score: 0.192
  12. Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway. Sci Rep. 2018 12 17; 8(1):17914.
    View in: PubMed
    Score: 0.179
  13. CRISPR/Cas9-mediated reversibly immortalized mouse bone marrow stromal stem cells (BMSCs) retain multipotent features of mesenchymal stem cells (MSCs). Oncotarget. 2017 Dec 19; 8(67):111847-111865.
    View in: PubMed
    Score: 0.167
  14. lncRNA H19 mediates BMP9-induced osteogenic differentiation of mesenchymal stem cells (MSCs) through Notch signaling. Oncotarget. 2017 Jun 27.
    View in: PubMed
    Score: 0.162
  15. lncRNA H19 mediates BMP9-induced osteogenic differentiation of mesenchymal stem cells (MSCs) through Notch signaling. Oncotarget. 2017 Aug 08; 8(32):53581-53601.
    View in: PubMed
    Score: 0.162
  16. An NgAgo tool for genome editing: did CRISPR/Cas9 just find a competitor? Genes Dis. 2016 Sep; 3(3):169-170.
    View in: PubMed
    Score: 0.151
  17. A thermoresponsive polydiolcitrate-gelatin scaffold and delivery system mediates effective bone formation from BMP9-transduced mesenchymal stem cells. Biomed Mater. 2016 Apr 21; 11(2):025021.
    View in: PubMed
    Score: 0.149
  18. The Calcium-Binding Protein S100A6 Accelerates Human Osteosarcoma Growth by Promoting Cell Proliferation and Inhibiting Osteogenic Differentiation. Cell Physiol Biochem. 2015; 37(6):2375-92.
    View in: PubMed
    Score: 0.145
  19. The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies. Lab Invest. 2016 Feb; 96(2):116-36.
    View in: PubMed
    Score: 0.145
  20. Molecular pathogenesis and therapeutic strategies of human osteosarcoma. J Biomed Res. 2015 Aug 30; 30.
    View in: PubMed
    Score: 0.143
  21. Insider information: Testing cancer drug sensitivity for personalized therapy. Genes Dis. 2015 Sep; 2(3):219-221.
    View in: PubMed
    Score: 0.140
  22. Sustained high level transgene expression in mammalian cells mediated by the optimized piggyBac transposon system. Genes Dis. 2015 Mar; 2(1):96-105.
    View in: PubMed
    Score: 0.138
  23. A simplified and versatile system for the simultaneous expression of multiple siRNAs in mammalian cells using Gibson DNA Assembly. PLoS One. 2014; 9(11):e113064.
    View in: PubMed
    Score: 0.135
  24. The piggyBac transposon-mediated expression of SV40 T antigen efficiently immortalizes mouse embryonic fibroblasts (MEFs). PLoS One. 2014; 9(5):e97316.
    View in: PubMed
    Score: 0.131
  25. Overexpression of Ad5 precursor terminal protein accelerates recombinant adenovirus packaging and amplification in HEK-293 packaging cells. Gene Ther. 2014 Jul; 21(7):629-37.
    View in: PubMed
    Score: 0.130
  26. Adenovirus-mediated efficient gene transfer into cultured three-dimensional organoids. PLoS One. 2014; 9(4):e93608.
    View in: PubMed
    Score: 0.129
  27. Adenovirus-mediated gene transfer in mesenchymal stem cells can be significantly enhanced by the cationic polymer polybrene. PLoS One. 2014; 9(3):e92908.
    View in: PubMed
    Score: 0.129
  28. Crosstalk between Wnt/ß-catenin and estrogen receptor signaling synergistically promotes osteogenic differentiation of mesenchymal progenitor cells. PLoS One. 2013; 8(12):e82436.
    View in: PubMed
    Score: 0.126
  29. Modulation of ß-catenin signaling by the inhibitors of MAP kinase, tyrosine kinase, and PI3-kinase pathways. Int J Med Sci. 2013; 10(13):1888-98.
    View in: PubMed
    Score: 0.126
  30. The E-F hand calcium-binding protein S100A4 regulates the proliferation, survival and differentiation potential of human osteosarcoma cells. Cell Physiol Biochem. 2013; 32(4):1083-96.
    View in: PubMed
    Score: 0.126
  31. Characterization of scaffold carriers for BMP9-transduced osteoblastic progenitor cells in bone regeneration. J Biomed Mater Res A. 2014 Oct; 102(10):3429-38.
    View in: PubMed
    Score: 0.126
  32. BMP signaling in mesenchymal stem cell differentiation and bone formation. J Biomed Sci Eng. 2013 Aug; 6(8A):32-52.
    View in: PubMed
    Score: 0.124
  33. Decellularized liver scaffolds effectively support the proliferation and differentiation of mouse fetal hepatic progenitors. J Biomed Mater Res A. 2014 Apr; 102(4):1017-25.
    View in: PubMed
    Score: 0.122
  34. BMP9 signaling in stem cell differentiation and osteogenesis. Am J Stem Cells. 2013; 2(1):1-21.
    View in: PubMed
    Score: 0.120
  35. Wnt signaling in bone formation and its therapeutic potential for bone diseases. Ther Adv Musculoskelet Dis. 2013 Feb; 5(1):13-31.
    View in: PubMed
    Score: 0.119
  36. Growth hormone synergizes with BMP9 in osteogenic differentiation by activating the JAK/STAT/IGF1 pathway in murine multilineage cells. J Bone Miner Res. 2012 Jul; 27(7):1566-75.
    View in: PubMed
    Score: 0.115
  37. Conditional immortalization establishes a repertoire of mouse melanocyte progenitors with distinct melanogenic differentiation potential. J Invest Dermatol. 2012 Oct; 132(10):2479-2483.
    View in: PubMed
    Score: 0.114
  38. Conditionally immortalized mouse embryonic fibroblasts retain proliferative activity without compromising multipotent differentiation potential. PLoS One. 2012; 7(2):e32428.
    View in: PubMed
    Score: 0.112
  39. Epigenetic regulation of mesenchymal stem cells: a focus on osteogenic and adipogenic differentiation. Stem Cells Int. 2011; 2011:201371.
    View in: PubMed
    Score: 0.107
  40. BMP-9 induced osteogenic differentiation of mesenchymal stem cells: molecular mechanism and therapeutic potential. Curr Gene Ther. 2011 Jun; 11(3):229-40.
    View in: PubMed
    Score: 0.106
  41. Defective osteogenic differentiation in the development of osteosarcoma. Sarcoma. 2011; 2011:325238.
    View in: PubMed
    Score: 0.104
  42. The therapeutic potential of the Wnt signaling pathway in bone disorders. Curr Mol Pharmacol. 2011 Jan; 4(1):14-25.
    View in: PubMed
    Score: 0.103
  43. Mesenchymal Progenitor Cells and Their Orthopedic Applications: Forging a Path towards Clinical Trials. Stem Cells Int. 2010 Dec 16; 2010:519028.
    View in: PubMed
    Score: 0.103
  44. Lysophosphatidic acid acyltransferase ß (LPAATß) promotes the tumor growth of human osteosarcoma. PLoS One. 2010 Dec 01; 5(12):e14182.
    View in: PubMed
    Score: 0.103
  45. Tetrandrine inhibits Wnt/ß-catenin signaling and suppresses tumor growth of human colorectal cancer. Mol Pharmacol. 2011 Feb; 79(2):211-9.
    View in: PubMed
    Score: 0.102
  46. Mesenchymal stem cells: Molecular characteristics and clinical applications. World J Stem Cells. 2010 Aug 26; 2(4):67-80.
    View in: PubMed
    Score: 0.101
  47. TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells. J Biol Chem. 2010 Sep 17; 285(38):29588-98.
    View in: PubMed
    Score: 0.100
  48. Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma. Clin Cancer Res. 2010 Apr 15; 16(8):2235-45.
    View in: PubMed
    Score: 0.098
  49. Therapeutic Implications of PPARgamma in Human Osteosarcoma. PPAR Res. 2010; 2010:956427.
    View in: PubMed
    Score: 0.097
  50. Molecular basis of differentiation therapy for soft tissue sarcomas. Trends Cancer Res. 2010; 6:69-90.
    View in: PubMed
    Score: 0.096
  51. Activation of RXR and RAR signaling promotes myogenic differentiation of myoblastic C2C12 cells. Differentiation. 2009 Nov; 78(4):195-204.
    View in: PubMed
    Score: 0.093
  52. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev. 2009 May; 18(4):545-59.
    View in: PubMed
    Score: 0.092
  53. Hey1 basic helix-loop-helix protein plays an important role in mediating BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. J Biol Chem. 2009 Jan 02; 284(1):649-659.
    View in: PubMed
    Score: 0.089
  54. BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signalling. J Cell Mol Med. 2009 Aug; 13(8B):2448-2464.
    View in: PubMed
    Score: 0.089
  55. Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects. Lab Invest. 2008 Dec; 88(12):1264-77.
    View in: PubMed
    Score: 0.088
  56. Osteosarcoma development and stem cell differentiation. Clin Orthop Relat Res. 2008 Sep; 466(9):2114-30.
    View in: PubMed
    Score: 0.087
  57. Regulation of osteogenic differentiation during skeletal development. Front Biosci. 2008 Jan 01; 13:2001-21.
    View in: PubMed
    Score: 0.084
  58. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res. 2007 May; 25(5):665-77.
    View in: PubMed
    Score: 0.080
  59. Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing. Gene. 2007 Jun 15; 395(1-2):160-9.
    View in: PubMed
    Score: 0.079
  60. Wnt signaling and human diseases: what are the therapeutic implications? Lab Invest. 2007 Feb; 87(2):97-103.
    View in: PubMed
    Score: 0.078
  61. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc. 2007; 2(5):1236-47.
    View in: PubMed
    Score: 0.078
  62. CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol. 2006 Apr; 26(8):2955-64.
    View in: PubMed
    Score: 0.074
  63. Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma. Cancer Lett. 2005 Nov 08; 229(1):135-48.
    View in: PubMed
    Score: 0.072
  64. Gene therapy for spinal fusion. Spine J. 2005 Nov-Dec; 5(6 Suppl):250S-258S.
    View in: PubMed
    Score: 0.072
  65. Gene therapy for bone regeneration. Curr Gene Ther. 2005 Apr; 5(2):167-79.
    View in: PubMed
    Score: 0.069
  66. An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin Exp Metastasis. 2005; 22(4):319-29.
    View in: PubMed
    Score: 0.068
  67. Wnt/beta-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets. 2004 Dec; 4(8):653-71.
    View in: PubMed
    Score: 0.068
  68. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem. 2004 Dec 31; 279(53):55958-68.
    View in: PubMed
    Score: 0.067
  69. Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J Biol Chem. 2004 Jul 30; 279(31):32941-9.
    View in: PubMed
    Score: 0.065
  70. Dual regulation of gene expression mediated by tetracycline and Cre recombinase. Biotechniques. 2004 Mar; 36(3):390-2, 394, 396.
    View in: PubMed
    Score: 0.064
  71. Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling. J Cell Biochem. 2003 Dec 15; 90(6):1149-65.
    View in: PubMed
    Score: 0.063
  72. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am. 2003 Aug; 85(8):1544-52.
    View in: PubMed
    Score: 0.062
  73. Correction: BMP9-regulated angiogenic signaling plays an important role in the osteogenic differentiation of mesenchymal progenitor cells. J Cell Sci. 2023 Jun 01; 136(11).
    View in: PubMed
    Score: 0.061
  74. Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity. Cancer Lett. 2003 Apr 25; 193(2):161-70.
    View in: PubMed
    Score: 0.061
  75. Long noncoding RNA (lncRNA) H19: An essential developmental regulator with expanding roles in cancer, stem cell differentiation, and metabolic diseases. Genes Dis. 2023 Jul; 10(4):1351-1366.
    View in: PubMed
    Score: 0.060
  76. Canonical and noncanonical Wnt signaling: Multilayered mediators, signaling mechanisms and major signaling crosstalk. Genes Dis. 2024 Jan; 11(1):103-134.
    View in: PubMed
    Score: 0.060
  77. Corrigendum to "Characterization of the essential role of bone morphogenetic protein 9 (BMP9) in osteogenic differentiation of mesenchymal stem cells (MSCs) through RNA interference" [Genes & Diseases 5(2018):172-184]. Genes Dis. 2023 Mar; 10(2):632-637.
    View in: PubMed
    Score: 0.060
  78. Corrigendum to 'Modeling colorectal tumorigenesis using the organoids derived from conditionally immortalized mouse intestinal crypt cells (ciMICs)' [Genes Dis 8 (2021) 814-826]. Genes Dis. 2023 Mar; 10(2):618-619.
    View in: PubMed
    Score: 0.060
  79. Corrigendum to "The development of a sensitive fluorescent protein-based transcript reporter for high throughput screening of negative modulators of lncRNAs" [Genes & Diseases 5 (2018) 62-74]. Genes Dis. 2023 Mar; 10(2):627-629.
    View in: PubMed
    Score: 0.060
  80. Corrigendum to "Establishment and functional characterization of the reversibly immortalized mouse glomerular podocytes (imPODs)" [Genes & Diseases 5 (2018) 137-149]. Genes Dis. 2023 Mar; 10(2):630-631.
    View in: PubMed
    Score: 0.060
  81. Niclosamide (NA) overcomes cisplatin resistance in human ovarian cancer. Genes Dis. 2023 Jul; 10(4):1687-1701.
    View in: PubMed
    Score: 0.059
  82. SV40 large T antigen-induced immortalization reprograms mouse cardiomyocyte progenitors with mesenchymal stem cell characteristics and osteogenic potential. Genes Dis. 2023 Jul; 10(4):1161-1164.
    View in: PubMed
    Score: 0.059
  83. Modeling lung diseases using reversibly immortalized mouse pulmonary alveolar type 2 cells (imPAC2). Cell Biosci. 2022 Sep 22; 12(1):159.
    View in: PubMed
    Score: 0.058
  84. Engineered nucleus-free mesenchymal stem cells (MSCs) for the targeted delivery of therapeutics to disease site. Genes Dis. 2023 Mar; 10(2):310-312.
    View in: PubMed
    Score: 0.058
  85. Carboxymethyl chitosan prolongs adenovirus-mediated expression of IL-10 and ameliorates hepatic fibrosis in a mouse model. Bioeng Transl Med. 2022 Sep; 7(3):e10306.
    View in: PubMed
    Score: 0.056
  86. Integrative analysis of immune-related multi-omics profiles identifies distinct prognosis and tumor microenvironment patterns in osteosarcoma. Mol Oncol. 2022 06; 16(11):2174-2194.
    View in: PubMed
    Score: 0.055
  87. A one-step construction of adenovirus (OSCA) system using the Gibson DNA Assembly technology. Mol Ther Oncolytics. 2021 Dec 17; 23:602-611.
    View in: PubMed
    Score: 0.055
  88. Reversibly immortalized keratinocytes (iKera) facilitate re-epithelization and skin wound healing: Potential applications in cell-based skin tissue engineering. Bioact Mater. 2022 Mar; 9:523-540.
    View in: PubMed
    Score: 0.054
  89. Antiparasitic mebendazole (MBZ) effectively overcomes cisplatin resistance in human ovarian cancer cells by inhibiting multiple cancer-associated signaling pathways. Aging (Albany NY). 2021 07 07; 13(13):17407-17427.
    View in: PubMed
    Score: 0.054
  90. Argonaute (AGO) proteins play an essential role in mediating BMP9-induced osteogenic signaling in mesenchymal stem cells (MSCs). Genes Dis. 2021 Nov; 8(6):918-930.
    View in: PubMed
    Score: 0.053
  91. BMP9-initiated osteogenic/odontogenic differentiation of mouse tooth germ mesenchymal cells (TGMCS) requires Wnt/ß-catenin signalling activity. J Cell Mol Med. 2021 03; 25(5):2666-2678.
    View in: PubMed
    Score: 0.052
  92. Modeling colorectal tumorigenesis using the organoids derived from conditionally immortalized mouse intestinal crypt cells (ciMICs). Genes Dis. 2021 Nov; 8(6):814-826.
    View in: PubMed
    Score: 0.052
  93. Long non-coding RNA (LncRNA) HOTAIR regulates BMP9-induced osteogenic differentiation by targeting the proliferation of mesenchymal stem cells (MSCs). Aging (Albany NY). 2021 01 10; 13(3):4199-4214.
    View in: PubMed
    Score: 0.052
  94. Ferroptosis as a novel form of regulated cell death: Implications in the pathogenesis, oncometabolism and treatment of human cancer. Genes Dis. 2022 Mar; 9(2):347-357.
    View in: PubMed
    Score: 0.051
  95. Blockade of IGF/IGF-1R signaling axis with soluble IGF-1R mutants suppresses the cell proliferation and tumor growth of human osteosarcoma. Am J Cancer Res. 2020; 10(10):3248-3266.
    View in: PubMed
    Score: 0.051
  96. Stem cell therapy for chronic skin wounds in the era of personalized medicine: From bench to bedside. Genes Dis. 2019 Dec; 6(4):342-358.
    View in: PubMed
    Score: 0.047
  97. Highly expressed BMP9/GDF2 in postnatal mouse liver and lungs may account for its pleiotropic effects on stem cell differentiation, angiogenesis, tumor growth and metabolism. Genes Dis. 2020 Jun; 7(2):235-244.
    View in: PubMed
    Score: 0.047
  98. Developing a Versatile Shotgun Cloning Strategy for Single-Vector-Based Multiplex Expression of Short Interfering RNAs (siRNAs) in Mammalian Cells. ACS Synth Biol. 2019 09 20; 8(9):2092-2105.
    View in: PubMed
    Score: 0.047
  99. The wonders of BMP9: From mesenchymal stem cell differentiation, angiogenesis, neurogenesis, tumorigenesis, and metabolism to regenerative medicine. Genes Dis. 2019 Sep; 6(3):201-223.
    View in: PubMed
    Score: 0.047
  100. A simplified system for the effective expression and delivery of functional mature microRNAs in mammalian cells. Cancer Gene Ther. 2020 06; 27(6):424-437.
    View in: PubMed
    Score: 0.046
  101. Transcriptomic landscape regulated by the 14 types of bone morphogenetic proteins (BMPs) in lineage commitment and differentiation of mesenchymal stem cells (MSCs). Genes Dis. 2019 Sep; 6(3):258-275.
    View in: PubMed
    Score: 0.046
  102. Reversibly immortalized human umbilical cord-derived mesenchymal stem cells (UC-MSCs) are responsive to BMP9-induced osteogenic and adipogenic differentiation. J Cell Biochem. 2018 11; 119(11):8872-8886.
    View in: PubMed
    Score: 0.044
  103. A blockade of PI3K? signaling effectively mitigates angiotensin II-induced renal injury and fibrosis in a mouse model. Sci Rep. 2018 Jul 20; 8(1):10988.
    View in: PubMed
    Score: 0.044
  104. Niclosamide Exhibits Potent Anticancer Activity and Synergizes with Sorafenib in Human Renal Cell Cancer Cells. Cell Physiol Biochem. 2018; 47(3):957-971.
    View in: PubMed
    Score: 0.043
  105. Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis. 2018 Jun; 5(2):77-106.
    View in: PubMed
    Score: 0.043
  106. Characterization of the essential role of bone morphogenetic protein 9 (BMP9) in osteogenic differentiation of mesenchymal stem cells (MSCs) through RNA interference. Genes Dis. 2018 Jun; 5(2):172-184.
    View in: PubMed
    Score: 0.043
  107. Establishment and functional characterization of the reversibly immortalized mouse glomerular podocytes (imPODs). Genes Dis. 2018 Jun; 5(2):137-149.
    View in: PubMed
    Score: 0.043
  108. The development of a sensitive fluorescent protein-based transcript reporter for high throughput screening of negative modulators of lncRNAs. Genes Dis. 2018 Mar; 5(1):62-74.
    View in: PubMed
    Score: 0.042
  109. Noncanonical Wnt signaling plays an important role in modulating canonical Wnt-regulated stemness, proliferation and terminal differentiation of hepatic progenitors. Oncotarget. 2017 Apr 18; 8(16):27105-27119.
    View in: PubMed
    Score: 0.040
  110. Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC). Oncotarget. 2017 Feb 21; 8(8):12968-12982.
    View in: PubMed
    Score: 0.040
  111. A Blockade of IGF Signaling Sensitizes Human Ovarian Cancer Cells to the Anthelmintic Niclosamide-Induced Anti-Proliferative and Anticancer Activities. Cell Physiol Biochem. 2016; 39(3):871-88.
    View in: PubMed
    Score: 0.038
  112. Immortalized Mouse Achilles Tenocytes Demonstrate Long-Term Proliferative Capacity While Retaining Tenogenic Properties. Tissue Eng Part C Methods. 2016 Mar; 22(3):280-9.
    View in: PubMed
    Score: 0.037
  113. Transition to resistance: An unexpected role of the EMT in cancer chemoresistance. Genes Dis. 2016 Mar; 3(1):3-6.
    View in: PubMed
    Score: 0.037
  114. Antibiotic monensin synergizes with EGFR inhibitors and oxaliplatin to suppress the proliferation of human ovarian cancer cells. Sci Rep. 2015 Dec 07; 5:17523.
    View in: PubMed
    Score: 0.036
  115. Multifaceted signaling regulators of chondrogenesis: Implications in cartilage regeneration and tissue engineering. Genes Dis. 2015 Dec; 2(4):307-327.
    View in: PubMed
    Score: 0.036
  116. Damage control: Harnessing prostaglandin E2 as a potential healing factor of tissue injuries. Genes Dis. 2015 Dec; 2(4):295-298.
    View in: PubMed
    Score: 0.036
  117. TqPCR: A Touchdown qPCR Assay with Significantly Improved Detection Sensitivity and Amplification Efficiency of SYBR Green qPCR. PLoS One. 2015; 10(7):e0132666.
    View in: PubMed
    Score: 0.035
  118. The Anthelmintic Drug Niclosamide Inhibits the Proliferative Activity of Human Osteosarcoma Cells by Targeting Multiple Signal Pathways. Curr Cancer Drug Targets. 2015; 15(8):726-38.
    View in: PubMed
    Score: 0.034
  119. Canonical Wnt signaling acts synergistically on BMP9-induced osteo/odontoblastic differentiation of stem cells of dental apical papilla (SCAPs). Biomaterials. 2015 Jan; 39:145-54.
    View in: PubMed
    Score: 0.034
  120. Functional characteristics of reversibly immortalized hepatic progenitor cells derived from mouse embryonic liver. Cell Physiol Biochem. 2014; 34(4):1318-38.
    View in: PubMed
    Score: 0.033
  121. Bone morphogenetic protein 2 inhibits the proliferation and growth of human colorectal cancer cells. Oncol Rep. 2014 Sep; 32(3):1013-20.
    View in: PubMed
    Score: 0.033
  122. Reversibly Immortalized Mouse Articular Chondrocytes Acquire Long-Term Proliferative Capability While Retaining Chondrogenic Phenotype. Cell Transplant. 2015; 24(6):1053-66.
    View in: PubMed
    Score: 0.033
  123. Characterization of constitutive promoters for piggyBac transposon-mediated stable transgene expression in mesenchymal stem cells (MSCs). PLoS One. 2014; 9(4):e94397.
    View in: PubMed
    Score: 0.032
  124. Bone morphogenetic protein-9 effectively induces osteo/odontoblastic differentiation of the reversibly immortalized stem cells of dental apical papilla. Stem Cells Dev. 2014 Jun 15; 23(12):1405-16.
    View in: PubMed
    Score: 0.032
  125. Targeting BMP9-promoted human osteosarcoma growth by inactivation of notch signaling. Curr Cancer Drug Targets. 2014; 14(3):274-85.
    View in: PubMed
    Score: 0.032
  126. Destabilization of heterologous proteins mediated by the GSK3ß phosphorylation domain of the ß-catenin protein. Cell Physiol Biochem. 2013; 32(5):1187-99.
    View in: PubMed
    Score: 0.031
  127. Endoplasmic reticulum (ER) stress inducible factor cysteine-rich with EGF-like domains 2 (Creld2) is an important mediator of BMP9-regulated osteogenic differentiation of mesenchymal stem cells. PLoS One. 2013; 8(9):e73086.
    View in: PubMed
    Score: 0.031
  128. Inhibition of histone deacetylases potentiates BMP9-induced osteogenic signaling in mouse mesenchymal stem cells. Cell Physiol Biochem. 2013; 32(2):486-98.
    View in: PubMed
    Score: 0.031
  129. Noggin resistance contributes to the potent osteogenic capability of BMP9 in mesenchymal stem cells. J Orthop Res. 2013 Nov; 31(11):1796-803.
    View in: PubMed
    Score: 0.031
  130. Cross-talk between EGF and BMP9 signalling pathways regulates the osteogenic differentiation of mesenchymal stem cells. J Cell Mol Med. 2013 Sep; 17(9):1160-72.
    View in: PubMed
    Score: 0.031
  131. Establishment and characterization of the reversibly immortalized mouse fetal heart progenitors. Int J Med Sci. 2013; 10(8):1035-46.
    View in: PubMed
    Score: 0.031
  132. IGFBP5 domains exert distinct inhibitory effects on the tumorigenicity and metastasis of human osteosarcoma. Cancer Lett. 2013 Aug 09; 336(1):222-30.
    View in: PubMed
    Score: 0.030
  133. Characterization of chondrocyte scaffold carriers for cell-based gene therapy in articular cartilage repair. J Biomed Mater Res A. 2013 Dec; 101(12):3542-50.
    View in: PubMed
    Score: 0.030
  134. The Current and Future Therapies for Human Osteosarcoma. Curr Cancer Ther Rev. 2013 Feb; 9(1):55-77.
    View in: PubMed
    Score: 0.030
  135. BMP9-regulated angiogenic signaling plays an important role in the osteogenic differentiation of mesenchymal progenitor cells. J Cell Sci. 2013 Jan 15; 126(Pt 2):532-41.
    View in: PubMed
    Score: 0.029
  136. All-trans retinoic acid inhibits tumor growth of human osteosarcoma by activating Smad signaling-induced osteogenic differentiation. Int J Oncol. 2012 Jul; 41(1):153-60.
    View in: PubMed
    Score: 0.028
  137. Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ß-catenin signaling. Int J Oncol. 2011 Feb; 38(2):437-45.
    View in: PubMed
    Score: 0.026
  138. Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation. J Bone Miner Res. 2010 Nov; 25(11):2447-59.
    View in: PubMed
    Score: 0.026
  139. Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS One. 2010 Jul 30; 5(7):e11917.
    View in: PubMed
    Score: 0.025
  140. The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis. Histol Histopathol. 2010 06; 25(6):795-806.
    View in: PubMed
    Score: 0.025
  141. Retinoic acid signalling induces the differentiation of mouse fetal liver-derived hepatic progenitor cells. Liver Int. 2009 Nov; 29(10):1569-81.
    View in: PubMed
    Score: 0.024
  142. Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells. J Cell Biochem. 2009 Sep 01; 108(1):295-303.
    View in: PubMed
    Score: 0.024
  143. Establishment and characterization of a new highly metastatic human osteosarcoma cell line. Clin Exp Metastasis. 2009; 26(7):599-610.
    View in: PubMed
    Score: 0.023
  144. BMP-14 gene therapy increases tendon tensile strength in a rat model of Achilles tendon injury. J Bone Joint Surg Am. 2007 Jun; 89(6):1315-20.
    View in: PubMed
    Score: 0.020
  145. Characterization of adenovirus-mediated gene transfer in rabbit flexor tendons. J Hand Surg Am. 2005 Jan; 30(1):136-41.
    View in: PubMed
    Score: 0.017
  146. Myoid differentiation and prognosis in adult pleomorphic sarcomas of the extremity: an analysis of 92 cases. Cancer. 2003 Aug 15; 98(4):805-13.
    View in: PubMed
    Score: 0.015
  147. Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine (Phila Pa 1976). 2003 Apr 15; 28(8):755-63.
    View in: PubMed
    Score: 0.015
  148. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin. Int J Cancer. 2002 Oct 01; 101(4):301-10.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.